Agent fee percentage Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds Proceeds from issuance of pre-funded warrants, net of paid issuance costs Proceeds from Issuance of Warrants Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Prepaid expenses Increase (Decrease) in Prepaid Expense Schedule of Components of Lease Cost Lease, Cost [Table Text Block] Cover [Abstract] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Director Director [Member] Schedule of Future Contractual Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Trading Symbol Trading Symbol Maximum milestone payments Collaborative Arrangement, Maximum Milestone Payment Collaborative Arrangement, Maximum Milestone Payment All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Proceeds from warrant cancellation payment Proceeds From Cancellation Of Warrants Proceeds From Cancellation Of Warrants Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Preferred stock purchased Payments to Acquire Equity Securities, FV-NI Accounts receivable, net Increase (Decrease) in Accounts Receivable Realized/unrealized loss on equity investments Realized/unrealized loss on equity investments Equity Securities, FV-NI, Gain (Loss) Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Award Timing Disclosures [Line Items] 2016 Plan Equity Incentive Plan 2016 [Member] Equity Incentive Plan 2016 Other Performance Measure, Amount Other Performance Measure, Amount 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Operating lease expense Operating Lease, Cost Other receivables Other Receivables, Net, Current Operating lease liability, noncurrent Operating Lease, Liability, Noncurrent Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Operating Segment Segment Reporting, Policy [Policy Text Block] Plan Name [Domain] Plan Name [Domain] Original issue price (usd per share) Sale of Stock, Price Per Share Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Money market funds Money Market Funds [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Stock issued, net proceeds Sale of Stock, Consideration Received on Transaction Cash Flows From Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] U.S. Treasury securities US Treasury Securities [Member] Raw materials Inventory, Raw Materials, Noncurrent, Net of Reserves Inventory, Raw Materials, Noncurrent, Net of Reserves Plan Name [Axis] Plan Name [Axis] Prepaid expenses Prepaid Expense, Current Equity Components [Axis] Equity Components [Axis] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Award Timing Method Award Timing Method [Text Block] Office equipment Office Equipment [Member] Non-cash lease expense Operating Lease, Noncash Expense Operating Lease, Noncash Expense Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Corporate debt securities Debt Securities, Available-for-Sale Accounts Receivable, Net Accounts Receivable [Policy Text Block] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Use of Estimates Use of Estimates, Policy [Policy Text Block] Total operating expenses Costs and Expenses Adjustment to Compensation, Amount Adjustment to Compensation Amount Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Smaller Reporting Company Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Payment of debt issuance costs Payments of Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Contractual milestone payment net sales Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Shares issued in warrant conversion (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Debt Securities, Available-for-Sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Shares issued in connection with the employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Antidilutive securities excluded from computation of net income (loss) per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cost of Sales Cost of Goods and Service [Policy Text Block] Cash and cash equivalents — beginning of period Cash and cash equivalents — end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Net amortization/accretion of marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Pharmakon Credit Facility, Tranche One Pharmakon Credit Facility, Tranche One [Member] Pharmakon Credit Facility, Tranche One Current assets: Assets, Current [Abstract] Common stock awards reserved for future issuance under 2020 and 2016 Equity Incentive Plans (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Milestone Determined by the Company Milestone Determined by the Company [Member] Milestone Determined by the Company Number of leases Lessee, Operating Lease, Number Of Lease Contracts Lessee, Operating Lease, Number Of Lease Contracts Other comprehensive gain: Other Comprehensive Income (Loss), Net of Tax [Abstract] Consulting Agreements Consulting Agreements [Member] Consulting Agreements Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Prime Rate Prime Rate [Member] Product and Service [Domain] Product and Service [Domain] Stock options Stock options, unexercised — vested and unvested Share-Based Payment Arrangement, Option [Member] Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Vested (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Fair Value Disclosures [Abstract] Depreciation Depreciation Marketable securities Marketable Securities, Current 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Additional cash payment Revenue, Remaining Performance Obligation, Additional Cash Payment Revenue, Remaining Performance Obligation, Additional Cash Payment Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Other receivables Increase (Decrease) in Other Receivables Security Exchange Name Security Exchange Name Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Award Type [Axis] Award Type [Axis] Purchases of long-term investments Payments to Acquire Long-Term Investments Related Party Transaction [Domain] Related Party Transaction [Domain] Corporate debt securities Corporate Debt Securities [Member] Earnings Per Share, Basic [Abstract] Earnings Per Share, Basic [Abstract] Exercised (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of vested warrants Number Of Vested Warrants Number Of Vested Warrants End of term charge, interest rate (as a percent) Line of Credit Facility, Periodic Payment, Interest Rate Line of Credit Facility, Periodic Payment, Interest Rate Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Work in progress Inventory, Work in Process, Net of Reserves Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net 2023 ATM Prospectus 2023 ATM Prospectus [Member] 2023 ATM Prospectus Total liabilities Liabilities Special cash dividend (usd per share) Common Stock, Dividends, Per Share, Cash Paid Exercisable (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Estimated Value of Cash, Cash Equivalents, Marketable Securities, and Equity Securities Unrealized Gain (Loss) on Investments [Table Text Block] Expiration Date Trading Arrangement Expiration Date Follow-On Public Offering Follow-On Public Offering [Member] Follow-On Public Offering Cash Flows From Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] License And Collaboration, Other License And Collaboration, Other [Member] License And Collaboration, Other Operating lease liability, current Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, issued (in shares) Common Stock, Shares, Issued Unvested Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value Entity [Domain] Entity [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Credit facility, aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Concentration risk Concentration Risk, Percentage Upfront payment received Collaborative Arrangement, Rights And Obligations, Upfront Payment Collaborative Arrangement, Rights And Obligations, Upfront Payment Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] (Less): Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Pre-funded warrants reserved for future issuance (in shares) Class of Warrant Or Right, Reserved for Future Issuance Class of Warrant Or Right, Reserved for Future Issuance Subsequent Event [Line Items] Subsequent Event [Line Items] Property and equipment, at cost Property, Plant and Equipment, Gross Pharmakon Credit Facility Pharmakon Credit Facility [Member] Pharmakon Credit Facility Exercise of vested stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Research and development Research and Development Expense [Member] Common stock, authorized (in shares) Common Stock, Shares Authorized Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted-average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Unrealized gain on marketable securities and cash equivalents OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] 2024 (remaining three months) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Future cash payments Collaborative Arrangement, Future Cash Payments Collaborative Arrangement, Future Cash Payments Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] OUT-LICENSE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Related Party Related Party [Member] Interest expense Interest Expense, Nonoperating Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Cost of sales Cost of Sales [Member] Product Product [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Sale of Stock [Domain] Sale of Stock [Domain] Long-term debt, net Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Commercial Sales Milestone Payments Commercial Sales Milestone Payments [Member] Commercial Sales Milestone Payments Unvested Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term ASSETS Assets: Assets [Abstract] Sponsorship Activities Sponsorship Activities [Member] Sponsorship Activities Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Dividend yield rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Document Type Document Type Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Commercial paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Net proceeds Proceeds from (Repayments of) Debt Issuance of common stock upon the vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Interest expense for long-term debt Interest Expense, Debt, Excluding Amortization Equity securities (in shares) Equity Securities, FV-NI, Number Of Shares Equity Securities, FV-NI, Number Of Shares Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Tranches with minimum net sales milestones Debt Instrument, Number Of Tranches With Milestone Requirements Debt Instrument, Number Of Tranches With Milestone Requirements Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Amortized cost Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Schedule of Expected Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Weighted average risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Subsequent Event [Table] Subsequent Event [Table] Maximum Maximum [Member] Marketable securities: Debt Securities, Available-for-Sale [Abstract] Amortization of intangible assets Amortization of Intangible Assets Upfront payment Contract with Customer, Liability Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Total future amortization Finite-Lived Intangible Assets, Net Royalty expense Royalty Expense Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounting Policies [Abstract] Revenues: Revenues [Abstract] Leasehold improvements Leasehold Improvements [Member] Upon Execution of the Novation Agreement Upon Execution of the Novation Agreement [Member] Upon Execution of the Novation Agreement Schedule of Valuation Assumptions of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Current Fiscal Year End Date Current Fiscal Year End Date (Less): Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Five Customers Five Customers [Member] Five Customers Upon Execution of Warrant Termination Agreement Upon Execution of Warrant Termination Agreement [Member] Upon Execution of Warrant Termination Agreement Total lease expense Lease, Cost Accounts payable and other accrued liabilities Accounts payable and other accrued liabilities Accounts Payable and Other Accrued Liabilities, Current Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name License agreement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] LianBio LianBio [Member] LianBio Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Award Type [Domain] Award Type [Domain] Name Outstanding Recovery, Individual Name Offering costs included within accounts payable and accrued liabilities Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities Variable lease expense Variable Lease, Cost Schedule of Outstanding Potentially Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Restricted stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Title of Individual [Axis] Title and Position [Axis] Useful life (in years) Finite-Lived Intangible Asset, Useful Life Additional Paid-In Capital Additional Paid-in Capital [Member] Related party transaction, termination notice, period Related Part Transaction, Termination Notice, Period Related Part Transaction, Termination Notice, Period Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Number of tranches Warrant Agreement, Number of Tranches Warrant Agreement, Number of Tranches Recently Issued or Effective Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Net loss per share - diluted (usd per share) Earnings Per Share, Diluted Title of Individual [Domain] Title and Position [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Number of operating segments Number of Operating Segments Number of securities with contractual maturity between one and three years Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities Preferred stock, issued (in shares) Preferred Stock, Shares Issued Customer [Axis] Customer [Axis] Accounts payable and other accrued liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Unrealized loss from transactions denominated in a foreign currency Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Statement of Financial Position [Abstract] Unvested (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Interest rate floor (as a percent) Debt Instrument, Floor Interest Rate Debt Instrument, Floor Interest Rate Stock-based compensation Share-Based Payment Arrangement, Noncash Expense End of term charge Line of Credit Facility, Periodic Payment, Interest Accrued branded prescription drug fee Accrued Branded Prescription Drug Fee, Current Accrued Branded Prescription Drug Fee, Current Other income (expense): Nonoperating Income (Expense) [Abstract] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Issuance of pre-funded warrants, net of issuance costs of $0.6 million Adjustments to Additional Paid in Capital, Warrant Issued Common stock in LianBio Estimated fair value Equity Securities, FV-NI Unrecognized compensation expense, weighted average period of recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue recognized Revenue from Contract with Customer, Excluding Assessed Tax Intangible asset additions Payments to Acquire Intangible Assets Total other income, net Nonoperating Income (Expense) Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Grandpharma Grandpharma [Member] Grandpharma Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Loss from operations before other income (expense) Operating Income (Loss) Variable Rate [Domain] Variable Rate [Domain] Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ equity Liabilities and Equity SUBSEQUENT EVENTS Subsequent Events [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accrued payroll and benefits Employee-related Liabilities, Current Marketable Securities and Long-Term Investments Marketable Securities, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Legal Entity [Axis] Legal Entity [Axis] Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Operating lease right-of-use asset obtained in exchange for operating lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Development and Regulatory Milestone Development And Regulatory Milestone [Member] Development And Regulatory Milestone Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Related Party Transaction [Axis] Related Party Transaction [Axis] Accumulated Other Comprehensive Gain (Loss) AOCI Attributable to Parent [Member] Line of Credit, SVB Line of Credit, SVB [Member] Line of Credit, SVB Forfeited (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Inventory Inventory Inventory, Net Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Commercial and sales milestones Commercial And Sales Milestones [Member] Commercial And Sales Milestones Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Trade accounts payable and other Accounts Payable, Trade, Current Operating expenses: Operating Expenses [Abstract] Schedule of Property and Equipment, Net of Accumulated Depreciation Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Outstanding, beginning balance (usd per share) Outstanding, ending balance (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Issuance costs, warrants Class of Warrant or Right, Payments of Issuance Costs Class of Warrant or Right, Payments of Issuance Costs Intangible Assets, Milestone Payment Intangible Assets, Milestone Payment [Member] Intangible Assets, Milestone Payment Weighted-Average Remaining Contractual Term Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value Contractual maturity Debt Securities, Available-for-Sale, Term Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Related Party Transactions [Abstract] Common stock votes Common Stock, Number Of Votes Common Stock, Number Of Votes Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Beginning balance (usd per share) Ending balance (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Stock options issued and outstanding (unvested and vested) under 2020 and 2016 Equity Incentive Plans (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Related party transaction, annual cash compensation Related Party Transaction, Annual Cash Compensation Related Party Transaction, Annual Cash Compensation Principal outstanding Long-term debt, gross Long-Term Debt, Gross Exercise Price Award Exercise Price NET LOSS PER SHARE Earnings Per Share [Text Block] Accrued payroll and benefits Increase (Decrease) in Employee Related Liabilities Arrangement Duration Trading Arrangement Duration Shares issued in connection with the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Subsequent Event Subsequent Event [Member] Accrued royalty payable Accrued Royalty Payable, Current Accrued Royalty Payable, Current Exercise of vested stock options Stock Issued During Period, Value, Stock Options Exercised Stockholders’ equity: Equity, Attributable to Parent [Abstract] Granted (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Long-term investments Long-Term Investments Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Draw on credit facility Proceeds from Lines of Credit Price per warrant (usd per share) Class of Warrant or Right, Sale Price Class of Warrant or Right, Sale Price PEO PEO [Member] Variable Rate [Axis] Variable Rate [Axis] Name Trading Arrangement, Individual Name Other income (expense), net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Other non-current assets Increase (Decrease) in Other Noncurrent Assets Remaining lease term Lessee, Operating Lease, Remaining Lease Term Proceeds from exercise of equity awards Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Total shares of common stock reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Related Party [Domain] Related and Nonrelated Parties [Domain] Accrued product sales deductions Accrued Sales Commission, Current Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Additions of intangible assets included within accounts payable and other accrued liabilities Intangible Assets Expenditures Incurred But Not Yet Paid Intangible Assets Expenditures Incurred But Not Yet Paid Local Phone Number Local Phone Number Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Debt issuance costs Debt Issuance Costs, Line of Credit Arrangements, Net Sales-based Milestones Sales-Based Milestones [Member] Sales-based Milestones Service condition period for full vesting (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] PEO Total Compensation Amount PEO Total Compensation Amount Fair market value of common stock (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Amortized cost Equity Securities, FV-NI, Cost Four Customers Four Customers [Member] Four Customers Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Entity Ex Transition Period Entity Ex Transition Period Pharmakon Credit Facility, Tranche Two Pharmakon Credit Facility, Tranche Two [Member] Pharmakon Credit Facility, Tranche Two Issuance costs Payments of Stock Issuance Costs Common stock issued for license agreement, value Stock Issued During Period, Value, Issued for Services COMMITMENTS & CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] (Less): Tenant improvement allowance Lessee, Operating Lease, Liability, Tenant Improvement Allowance Lessee, Operating Lease, Liability, Tenant Improvement Allowance Common stock issued for license agreement, share price (usd per share) Share Price Long-Lived Assets Held-for-Sale by Asset Type [Axis] Long-Lived Asset, Held-for-Sale, Type [Axis] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Issuance of common stock upon follow-on public offering, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Line of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company Intangible Assets, Net Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Entity Central Index Key Entity Central Index Key Restricted stock units — unvested Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested [Member] Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] License fees and Collaboration License And Collaboration [Member] License And Collaboration Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Financial Instrument [Axis] Financial Instrument [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Recognition of stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restricted common stock Restricted Stock [Member] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Available-for-sale Debt Securities, Contractual Maturity Less Than 12 Months Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months [Member] Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Clinical milestones Clinical Milestones [Member] Clinical Milestones Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Total interest expense Interest Expense, Debt Counterparty Name [Axis] Counterparty Name [Axis] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES Significant Accounting Policies [Text Block] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Interest expense paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activities Revenue Recognition Revenue [Policy Text Block] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Three Customers Three Customers [Member] Three Customers Total current assets Assets, Current Schedule of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Statement of Cash Flows [Abstract] Supplemental Disclosures Noncash and Other Investing and Financing Activities: Noncash Investing and Financing Items [Abstract] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-term debt, net Long-Term Debt, Excluding Current Maturities Weighted Average Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant-date fair value per stock option (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] Accumulated amortization of debt issuance costs Accumulated Amortization, Debt Issuance Costs 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Earnings Per Share [Abstract] Earnings Per Share [Abstract] Equity [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Accumulated deficit Retained Earnings (Accumulated Deficit) Related Party Transaction [Line Items] Related Party Transaction [Line Items] Inventory Increase (Decrease) in Inventories Schedule of Balances of Debt, Debt Issuance Costs, and Accumulated Accretion Schedule of Debt [Table Text Block] Selling, general and administrative General and Administrative Expense Common stock awards reserved for future issuance under the 2020 Employee Stock Purchase Plan (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Change in fair value of equity warrants issued by licensee Change in fair value of equity warrants issued by licensee Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Equity Awards Adjustments Equity Awards Adjustments [Member] Estimated incremental borrowing rate (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Total operating lease liability Total operating lease liability Operating Lease, Liability Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Payments for debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Elanco Elanco [Member] Elanco Line of credit facility, Interest Rate (as a percent) Line of Credit Facility, Interest Rate During Period Special cash dividends paid Dividends, Common Stock, Cash Interest income Interest Income, Other Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Potential additional tranches Debt Instrument, Number Of Potential Additional Tranches Debt Instrument, Number Of Potential Additional Tranches Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Number of available-for-sale debt securities in gross unrealized loss position for less than one year Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Long-term investments: Equity Securities, FV-NI [Abstract] Manufacturing equipment Machinery and Equipment [Member] Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Authorized consideration Sale of Stock, Consideration Amount Authorized Sale of Stock, Consideration Amount Authorized Subsequent Events [Abstract] Credit Facility, Tranche One Credit Facility, Tranche One [Member] Credit Facility, Tranche One Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Level 2 Fair Value, Inputs, Level 2 [Member] Stock issued (in shares) Sale of Stock, Number of Shares Issued in Transaction CREDIT FACILITY AGREEMENTS Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Remaining useful life Finite-Lived Intangible Assets, Remaining Amortization Period Unvested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Issuance of common stock upon follow-on public offering, net of issuance costs Stock Issued During Period, Value, New Issues Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Stock Based Compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Unrealized losses Equity Securities, FV-NI, Unrealized Loss Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Upfront payment received Upfront Payment Upfront Payment Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, $0.0001 par value; 200,000,000 shares authorized; 38,196,072 shares issued and outstanding at September 30, 2024 (unaudited); 34,211,190 shares issued and outstanding at December 31, 2023 Common Stock, Value, Issued Share-Based Payment Arrangement [Abstract] Government-related debt securities US Government Debt Securities [Member] Amortized cost Cash and Cash Equivalents, at Carrying Value Milestone payments to be achieved Revenue, Remaining Performance Obligation, Variable Consideration, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Amount Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Forfeited (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Loss on debt extinguishment Loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Impairments of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Cash Flows From Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Unrealized gains Equity Securities, FV-NI, Unrealized Gain Preferred stock, $0.0001 par value; 10,000,000 authorized; no shares issued and outstanding Preferred Stock, Value, Issued Useful lives of assets (in years) Property, Plant and Equipment, Useful Life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Employee stock Employee Stock [Member] Net loss per share - basic (usd per share) Earnings Per Share, Basic 2023 Shelf Registration Statement 2023 Shelf Registration Statement [Member] 2023 Shelf Registration Statement Proceeds from sale of common stock under employee stock purchase plan Proceeds from Stock Plans Proceeds from issuance of common stock, net of paid issuance costs Proceeds from Issuance of Common Stock Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Additions of property and equipment included within accounts payable and other accrued liabilities Capital Expenditures Incurred but Not yet Paid Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Property and Equipment, Net Property, Plant and Equipment, Policy [Policy Text Block] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Total assets Assets Concentration Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Weighted average volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Cost of sales Cost of Goods and Services Sold Pharmakon Credit Facility, Tranche Three Pharmakon Credit Facility, Tranche Three [Member] Pharmakon Credit Facility, Tranche Three Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Long-Lived Assets Held-for-Sale, Name [Domain] Long-Lived Assets Held-for-Sale, Name [Domain] Cash equivalents: Cash and Cash Equivalents [Abstract] Underwriters' option Over-Allotment Option [Member] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and contingencies (Note 7) Commitments and Contingencies Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Termination Date Trading Arrangement Termination Date DESCRIPTION OF BUSINESS AND PRESENTATION OF FINANCIAL STATEMENTS Business Description and Basis of Presentation [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Exercise price per warrant (usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Total revenues Revenues 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Common stock issued for license agreement (in shares) Stock Issued During Period, Shares, Issued for Services Leases Lessee, Leases [Policy Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total stock-based compensation Share-Based Payment Arrangement, Expense Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Accretion of end of term charge Amortization of Debt Discount (Premium) Granted (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt securities, available for sale and cash and cash equivalents Debt Securities, Available-For-Sale And Cash And Cash Equivalents Debt Securities, Available-For-Sale And Cash And Cash Equivalents Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Total assets measured at fair value Assets, Fair Value Disclosure Name Forgone Recovery, Individual Name 2024 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Accretion of end of term charge Debt Instrument, Unamortized Discount (Premium), Net Document Period End Date Document Period End Date Sale of Stock [Axis] Sale of Stock [Axis] Finished goods Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Number of employment arrangements with executive officers Number Of Employment Arrangements With Executive Officers Number Of Employment Arrangements With Executive Officers Total future lease payments, undiscounted Lessee, Operating Lease, Liability, to be Paid Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Insider Trading Arrangements [Line Items] BALANCE SHEET ACCOUNT DETAIL Supplemental Balance Sheet Disclosures [Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Schedule of Stock Details Schedule of Stock by Class [Table Text Block] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Total inventory Inventory, Current And Noncurrent, Net Inventory, Current And Noncurrent, Net Equity warrants terminated (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Number of directors Number Of Directors Number Of Directors Expanded The Size Adjustment to Compensation: Adjustment to Compensation [Axis] Accounts Receivable Accounts Receivable [Member] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Customer [Domain] Customer [Domain] Accumulated other comprehensive gain (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Non-current assets: Inventory, Noncurrent [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Laboratory equipment Other Machinery and Equipment [Member] Pharmakon Credit Facility, Tranche Four Pharmakon Credit Facility, Tranche Four [Member] Pharmakon Credit Facility, Tranche Four Related Party [Axis] Related and Nonrelated Parties [Axis] Weighted-average shares outstanding, basic (in shares) Weighted-average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Inventory, non-current Inventory, non-current Inventory, Noncurrent Restricted stock Restricted Stock Units (RSUs) [Member] Amortization of debt-related costs Amortization of Debt Issuance Costs and Discounts Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Equity warrants (for LianBio shares) Equity Warrants, Fair Value Disclosure Equity Warrants, Fair Value Disclosure Name Awards Close in Time to MNPI Disclosures, Individual Name Revenue Benchmark Revenue Benchmark [Member] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Entity Filer Category Entity Filer Category Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Company Selected Measure Name Company Selected Measure Name